Literature DB >> 6815088

Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation.

A M Hooke, P J Arroyo, M P Oeschger, J A Bellanti.   

Abstract

The immunogenicity of two temperature-sensitive (ts) mutants of Pseudomonas aeruginosa immunotype 1, isolated and characterized for the development of a safe, live vaccine strain, was evaluated in a mouse protection model. One mutant, A/10/25, had a limited "coasting" property (i.e., continued replication for two divisions) at the nonpermissive temperature (36 degrees C), whereas the other mutant, E/9/9, continued replication for five generations after transfer to 36 degrees C. Groups of 3- to 5-week-old ICR mice were immunized intraperitoneally with various doses of the two ts mutants; at various times thereafter, the mice were challenged intraperitoneally with lethal doses of the parental wild type. The more extensive coaster, E/9/9, induced 100% protection at immunizing doses lower than those required for A/10/25 to induce the same protection (1 x 10(8) to 2 x 10(8) and 6 x 10(8) colony-forming units, respectively). Both ts strains induced significant protection for up to 5 weeks after immunization. The results of these studies suggest that the use of P. aeruginosa ts mutants might provide a novel approach to the prevention of P. aeruginosa colonization of patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815088      PMCID: PMC347708          DOI: 10.1128/iai.38.1.136-140.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Oral immunization against experimental salmonellosis I. Development of temperature-sensitive mutant vaccines.

Authors:  K J Fahey; G N Cooper
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

2.  Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.

Authors:  J R Govan; J A Fyfe
Journal:  J Antimicrob Chemother       Date:  1978-05       Impact factor: 5.790

3.  Ideal target organism for quantitative bactericidal assays.

Authors:  A M Hooke; M P Oeschger; B J Zeligs; J A Bellanti
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

Review 4.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

5.  Mucoid Pseudomonas aeruginosa in patients with chronic illnesses.

Authors:  R G Doggett; G M Harrison; R E Carter
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

6.  Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors:  G B Pier; H F Sidberry; J C Sadoff
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

7.  A new polyvalent Pseudomonas vaccine.

Authors:  J M Miler; J F Spilsbury; R J Jones; E A Roe; E J Lowbury
Journal:  J Med Microbiol       Date:  1977-02       Impact factor: 2.472

8.  Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.

Authors:  J E Pennington; W F Hickey; L L Blackwood; M A Arnaut
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.

Authors:  O R Pavlovskis; D C Edman; S H Leppla; B Wretlind; L R Lewis; K E Martin
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.609

View more
  6 in total

1.  Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice.

Authors:  W Byrd; A M Hooke
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

2.  Differential growth characteristics and immunogenicity of tight and coasting temperature-sensitive mutants of Pseudomonas aeruginosa.

Authors:  A Morris Hooke; D O Sordelli; M C Cerquetti; J A Bellanti
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Enzyme-linked immunosorbent assay antibody responses to a temperature-sensitive mutant of Pseudomonas aeruginosa.

Authors:  D O Sordelli; R A Rojas; M C Cerquetti; A M Hooke; P J Degnan; J A Bellanti
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

4.  Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract.

Authors:  D O Sordelli; M C Cerquetti; A Morris Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

5.  Quantitative determination of bacterial replication in vivo.

Authors:  A Morris Hooke; D O Sordelli; M C Cerquetti; A J Vogt
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

6.  Biological evaluation of Mycoplasma pulmonis temperature-sensitive mutants for use as possible rodent vaccines.

Authors:  W C Lai; M Bennett; Y S Lu; S P Pakes
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.